Eylea (aflibercept) Disease area(s): Ophthalmology Manufacturer(s): Regeneron/Bayer 2024 Sales (USD): $9.55 billion Why it sold so well: Eylea registered strong sales in 2024, driven by the introduction of Eylea HD, which received FDA approval in 2023 and is an 8 mg formulation offering extended dosing intervals for retinal diseases
Suppliers with verified business licenses Audited by an independent third-party inspection agency Jinan Qinmu Fine Chemical Co.,Ltd
ROI analyses may complement whole-brain findings by providing increased sensitivity for hypothesis-driven questions, but results from these two approaches should be reported separately to facilitate future meta-analytic synthesis
As childhood obesity and youth-onset type 2 diabetes mellitus (T2DM) continue to rise worldwide, a new systematic review highlights glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as promising options that extend beyond lifestyle modification and metformin
Powerful Detoxification The liver relies heavily on glutathione to filter toxins, heavy metals, alcohol, and pollutants from the body
While medical weight management injections help support overall weight loss, some areas of fat can be more resistant than others
